128 related articles for article (PubMed ID: 3515180)
21. Plasmodium falciparum: isolation and characterization of a 55-kDa protease with a cathepsin D-like activity from P. falciparum.
Bailly E; Savel J; Mahouy G; Jaureguiberry G
Exp Parasitol; 1991 Apr; 72(3):278-84. PubMed ID: 2015866
[TBL] [Abstract][Full Text] [Related]
22. Parasite proteases and antimalarial activities of protease inhibitors.
Vander Jagt DL; Caughey WS; Campos NM; Hunsaker LA; Zanner MA
Prog Clin Biol Res; 1989; 313():105-18. PubMed ID: 2675111
[No Abstract] [Full Text] [Related]
23. The effect of ferriprotoporphyrin IX and chloroquine on phospholipid monolayers and the possible implications to antimalarial activity.
Ginsburg H; Demel RA
Biochim Biophys Acta; 1983 Jul; 732(1):316-9. PubMed ID: 6871197
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs.
Famin O; Krugliak M; Ginsburg H
Biochem Pharmacol; 1999 Jul; 58(1):59-68. PubMed ID: 10403519
[TBL] [Abstract][Full Text] [Related]
25. Hemolysis of mouse erythrocytes by ferriprotoporphyrin IX and chloroquine. Chemotherapeutic implications.
Chou AC; Fitch CD
J Clin Invest; 1980 Oct; 66(4):856-8. PubMed ID: 7419723
[TBL] [Abstract][Full Text] [Related]
26. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum.
Rosenthal PJ; McKerrow JH; Aikawa M; Nagasawa H; Leech JH
J Clin Invest; 1988 Nov; 82(5):1560-6. PubMed ID: 3053784
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of 37-kilodalton proteases from Plasmodium falciparum and Plasmodium berghei which cleave erythrocyte cytoskeletal components.
Deguercy A; Hommel M; Schrével J
Mol Biochem Parasitol; 1990 Jan; 38(2):233-44. PubMed ID: 2183048
[TBL] [Abstract][Full Text] [Related]
28. The state of ferriprotoporphyrin IX in malaria pigment.
Fitch CD; Kanjananggulpan P
J Biol Chem; 1987 Nov; 262(32):15552-5. PubMed ID: 3119578
[TBL] [Abstract][Full Text] [Related]
29. Ferriprotoporphyrin IX: role in chloroquine susceptibility and resistance in malaria.
Fitch CD
Prog Clin Biol Res; 1989; 313():45-52. PubMed ID: 2675116
[TBL] [Abstract][Full Text] [Related]
30. Human skin proteases. Separation and characterization of two acid proteases resembling cathepsin B1 and cathepsin D and of an inhibitor of cathepsin B1.
Fräki JE
Arch Dermatol Res (1975); 1976 Jun; 255(3):317-30. PubMed ID: 8017
[TBL] [Abstract][Full Text] [Related]
31. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway.
Gluzman IY; Francis SE; Oksman A; Smith CE; Duffin KL; Goldberg DE
J Clin Invest; 1994 Apr; 93(4):1602-8. PubMed ID: 8163662
[TBL] [Abstract][Full Text] [Related]
32. Heme polymerase: modulation by chloroquine treatment of a rodent malaria.
Chou AC; Fitch CD
Life Sci; 1992; 51(26):2073-8. PubMed ID: 1474861
[TBL] [Abstract][Full Text] [Related]
33. Relationship of chloroquine-induced redistribution of a neutral aminopeptidase to hemoglobin accumulation in malaria parasites.
Fitch CD; Cai GZ; Chen YF; Ryerse JS
Arch Biochem Biophys; 2003 Feb; 410(2):296-306. PubMed ID: 12573290
[TBL] [Abstract][Full Text] [Related]
34. Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin.
Kalkanidis M; Klonis N; Tilley L; Deady LW
Biochem Pharmacol; 2002 Mar; 63(5):833-42. PubMed ID: 11911834
[TBL] [Abstract][Full Text] [Related]
35. Mode of action of antimalarial drugs.
Fitch CD
Ciba Found Symp; 1983; 94():222-32. PubMed ID: 6341003
[TBL] [Abstract][Full Text] [Related]
36. Chloroquine-induced masking of a lipid that promotes ferriprotoporphyrin IX dimerization in malaria.
Fitch CD; Chen YF; Cai GZ
J Biol Chem; 2003 Jun; 278(25):22596-9. PubMed ID: 12697766
[TBL] [Abstract][Full Text] [Related]
37. Diverse membrane-active agents modify the hemolytic response to ferriprotoporphyrin IX.
Dutta P; Fitch CD
J Pharmacol Exp Ther; 1983 Jun; 225(3):729-34. PubMed ID: 6602875
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes.
Famin O; Ginsburg H
Biochem Pharmacol; 2002 Feb; 63(3):393-8. PubMed ID: 11853690
[TBL] [Abstract][Full Text] [Related]
39. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems.
Liu J; Istvan ES; Gluzman IY; Gross J; Goldberg DE
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8840-5. PubMed ID: 16731623
[TBL] [Abstract][Full Text] [Related]
40. Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease.
Goldberg DE; Slater AF; Beavis R; Chait B; Cerami A; Henderson GB
J Exp Med; 1991 Apr; 173(4):961-9. PubMed ID: 2007860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
